NPI: 1841618907 · BROWNS MILLS, NJ 08015 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/04/2014
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 04/04/2014 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,314 | $114K |
| 2019 | 3,271 | $304K |
| 2020 | 4,463 | $292K |
| 2021 | 3,115 | $198K |
| 2022 | 10,274 | $329K |
| 2023 | 4,143 | $299K |
| 2024 | 955 | $69K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 17,231 | 1,299 | $1.45M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 5,364 | 253 | $74K |
| J1270 | Injection, doxercalciferol, 1 mcg | 350 | 24 | $17K |
| A4657 | Syringe, with or without needle, each | 2,041 | 716 | $17K |
| 85048 | 323 | 295 | $12K | |
| 85041 | 323 | 295 | $12K | |
| J1756 | Injection, iron sucrose, 1 mg | 1,263 | 195 | $7K |
| 83550 | 127 | 113 | $5K | |
| 83540 | 130 | 115 | $5K | |
| 82728 | 126 | 113 | $3K | |
| 83970 | 133 | 123 | $3K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 17 | 14 | $4.88 |
| G0008 | Administration of influenza virus vaccine | 51 | 29 | $0.00 |
| 82108 | 27 | 24 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 29 | 12 | $0.00 |